Investors

We have very positive testimonials from end-users, such as Traveling Nurses Associations and Home Care Organizations that this system will directly save them time and money by eliminating the transportation of samples to the lab.

iAssay® is as a potential new revenue stream for these Home Care Organizations that have traditionally just drawn and transported samples to the lab.

 

iAssay® has built the core team, business & scientific advisory boards, developed a relationship with Wilson, Sonsini, Goodrich, and Rosati (a world class law firm), filed patents, developed strategic partners, validated POC tests in 4 different market segments on a Minimally Viable Product (MVP). It has begun to raise capital, and entered into a pilot program with National University / UCLA.

 

Demographics is a major contributing factor in the trend towards greater demand from home healthcare devices and services. According to the World Health Organization, the number of people who are 65 years and older is expected to increase to 2 billion by 2050 worldwide (from 605 million in 2000).

Competition

Feature iAssay Abbott iSTAT Alere Epoc
Market Segment: Physician
Market Segment: Home Health
Multi-Source Test Cartridges
Number of Compatible Test Cartridges 100+ 18 2
Simple to Operate
Wireless 3G/4G/NF/Wi-Fi Compatible
Bluetooth Vital Sign Sensor Compatible
Transparently Upgradable via Automatic Software Download
Automatically populates Eletronic Health Records
Facilitates Billing / Payment
Price $3K $6-14K $7-12K

 

The iAssay® business model is a consolidation play. This is a great opportunity to replace many costly devices with one device – iAssay®, affording our Content Partners, the chance to put all of their current tests onto our device.